| Health / Medical Topics |
SU014813
An orally-active, tyrosine kinase receptor inhibitor with potential antitumor activity. SU014813 binds to and inhibits the phosphorylation of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor (PDGFR) alpha and beta, c-Kit and Fms-related tyrosine kinase 3 (Flt-3). This leads to an inhibition of cellular proliferation and angiogenesis and an induction of apoptosis. (NCI Thesaurus)
YOU MAY ALSO LIKE
A drug used to treat certain types of pancreatic cancer. It is also used to treat gastrointestinal stromal tumors (GIST) in some…
A substance being studied in the treatment of cancer. SU006668 blocks proteins involved in the growth and spread of cancer cells. It…
A synthetic, colorless liquid that is very soluble in water. Styrene oxide is used as a chemical intermediate in the production of…
A thin metal wire designed to be passed through a needle, catheter, or cannula to stiffen it or clear it of…
A particular kind (as to appearance).
Stuttering is a problem that affects the flow of your speech. If you stutter, you may
